Abrdn Healthcare Investors (NYSE:HQH) Share Price Crosses Below Fifty Day Moving Average – What’s Next?

Abrdn Healthcare Investors (NYSE:HQH) shares passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $17.25 and traded as low as $16.54. Abrdn Healthcare Investors shares last traded at $16.74, with a volume of 209,411 shares changing hands.

Abrdn Healthcare Investors Trading Up 0.1 %

The firm’s fifty day moving average is $17.23 and its 200-day moving average is $18.06.

Abrdn Healthcare Investors Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Shareholders of record on Thursday, November 21st will be paid a dividend of $0.62 per share. This represents a $2.48 dividend on an annualized basis and a dividend yield of 14.81%. The ex-dividend date is Thursday, November 21st. This is a boost from Abrdn Healthcare Investors’s previous quarterly dividend of $0.59.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Truvestments Capital LLC bought a new stake in Abrdn Healthcare Investors during the 3rd quarter worth approximately $46,000. Northwest Investment Counselors LLC acquired a new position in Abrdn Healthcare Investors during the 3rd quarter worth about $57,000. TD Private Client Wealth LLC bought a new stake in shares of Abrdn Healthcare Investors in the 3rd quarter valued at about $66,000. EverSource Wealth Advisors LLC acquired a new stake in shares of Abrdn Healthcare Investors in the second quarter valued at about $93,000. Finally, Stifel Financial Corp bought a new position in shares of Abrdn Healthcare Investors during the third quarter worth about $188,000. 32.60% of the stock is currently owned by institutional investors.

About Abrdn Healthcare Investors

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.